Skip to main content
. 2019 Dec 19;6(3):e194489. doi: 10.1001/jamaoncol.2019.4489

Figure 1. Hazard Ratios for the Pairwise Comparisons of the Network Meta-analysis.

Figure 1.

Direct and indirect comparisons should be read from left to right. Hazard ratios for comparisons are in the cell in common between the column-defining and row-defining treatment. For progression-free survival, a hazard ratio of less than 1 favors row-defining treatment. For overall survival, a hazard ratio of less than 1 favors column-defining treatment. Bev indicates bevacizumab; CTX, continuing induction regimen; FP, fluoropyrimidine; MTC, maintenance; and OBS, observation.